Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
49.05
-0.12 (-0.24%)
Aug 10, 2026, 12:32 PM EDT - Market open
Alkermes Employees
Alkermes had 2,050 employees as of December 31, 2025. The number of employees increased by 250 or 13.89% compared to the previous year.
Employees
2,050
Change (1Y)
250
Growth (1Y)
13.89%
Revenue / Employee
$813,489
Profits / Employee
$32,255
Market Cap
8.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,050 | 250 | 13.89% |
| Dec 31, 2024 | 1,800 | -300 | -14.29% |
| Dec 31, 2023 | 2,100 | -180 | -7.89% |
| Dec 31, 2022 | 2,280 | 69 | 3.12% |
| Dec 31, 2021 | 2,211 | -34 | -1.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Neurocrine Biosciences | 2,000 |
| United Therapeutics | 1,400 |
| Lantheus Holdings | 1,193 |
ALKS News
- 12 days ago - Alkermes price target raised to $61 from $60 at JPMorgan - TheFly
- 12 days ago - Alkermes price target raised to $58 from $48 at Baird - TheFly
- 13 days ago - Alkermes sinks 5% to $50.05 following Q2 report - TheFly
- 13 days ago - Alkermes Earnings Call Transcript: Q2 2026 - Transcripts
- 13 days ago - Alkermes Earnings release: Q2 2026 - Filings
- 13 days ago - Alkermes Slides: Q2 2026 - Filings
- 13 days ago - Alkermes Quarterly report: Q2 2026 - Filings
- 13 days ago - Alkermes reaffirms FY26 revenue view $1.73B-$1.84B, consensus $1.81B - TheFly